AML (Acute Myeloid Leukemia)
1 competing product in clinical development for AML (Acute Myeloid Leukemia).
Pipeline by Phase
Phase 2/31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Gilteritinib + Venetoclax + Azacitidine (AZA) + Local standard of care (SOC) | Astellas Pharma | Phase 2/3 | Recruiting | 45 |